Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.
about
Clinically significant psychotropic drug-drug interactions in the primary care setting.Clinical pharmacology in sleep medicine.Thermodynamics of ligand binding to P450 2B4 and P450eryF studied by isothermal titration calorimetry.Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?(13)C breath tests in personalized medicine: fiction or reality?Metabolism of ophthalmic timolol: new aspects of an old drug.Therapeutic challenges posed by critical drug-drug interactions in cystic fibrosis.Antipsychotic-induced priapism in an HIV patient: a cytochrome P450-mediated drug interaction.Topical timolol for treatment of epistaxis in hereditary haemorrhagic telangiectasia associated with bradycardia: a look at CYP2D6 metabolising variants.Adverse drug reactions as the cause of emergency department admission: focus on the elderly.Drug-drug interactions in general hospital and psychiatric hospital in-patients prescribed psychotropic medications.Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.Use of RNA-seq to determine variation in canine cytochrome P450 mRNA expression between blood, liver, lung, kidney and duodenum in healthy beagles.
P2860
Q35104220-93B17A4A-E0AB-45C6-AFE3-4DB11D106973Q36417984-5ED24451-A6A1-459C-8A9A-46125E9CEA3DQ36929614-CEC166E4-DFFD-412A-A214-B6D0ED2C35AEQ37271799-F1CBE96F-2278-4E9E-94A7-5B9728DCA44EQ37628680-791B0865-FFD8-404B-8644-D59B78C2F1BCQ37850837-169CC1BF-218C-4D1C-9775-C71808832FE3Q38962747-4FE27FBB-C0AE-47F4-B16B-1C393647C03AQ41050435-D88B4950-F561-4E99-936D-2A24A2481D4FQ41959654-07E6294B-8D2F-4598-A78B-A5F8C4C2A370Q43185920-3ABDB74E-7421-43CD-83E2-6DDDA3E85149Q43727588-56BEBA34-6E22-40AF-A5CD-33A25D42868DQ44502093-4732C812-8FE6-476E-B9F4-F5EAC930D553Q47823254-3A34C704-C34A-4159-995C-E51E66384AB5
P2860
Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Bench to bedside: Pharmacogeno ...... nd the cytochrome P450 system.
@ast
Bench to bedside: Pharmacogeno ...... nd the cytochrome P450 system.
@en
Bench to bedside: Pharmacogeno ...... nd the cytochrome P450 system.
@nl
type
label
Bench to bedside: Pharmacogeno ...... nd the cytochrome P450 system.
@ast
Bench to bedside: Pharmacogeno ...... nd the cytochrome P450 system.
@en
Bench to bedside: Pharmacogeno ...... nd the cytochrome P450 system.
@nl
prefLabel
Bench to bedside: Pharmacogeno ...... nd the cytochrome P450 system.
@ast
Bench to bedside: Pharmacogeno ...... nd the cytochrome P450 system.
@en
Bench to bedside: Pharmacogeno ...... nd the cytochrome P450 system.
@nl
P2093
P2860
P1476
Bench to bedside: Pharmacogeno ...... nd the cytochrome P450 system.
@en
P2093
Andrew Ulrich
Brendan Magauran
Michael Shannon
Rishi Sikka
P2860
P304
P356
10.1111/J.1553-2712.2005.TB01503.X
P577
2005-11-10T00:00:00Z